Showing results (61-70 of 77) with videos related to
Sort By:
Pageof 8
European Journal of Internal Medicine|November 14, 2025
Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world dataMauro Gori, Luca Fazzini, Jennifer Meessen, et al.European Journal of Internal Medicine|January 30, 2026
Impact of chronic kidney disease on treatment implementation and prognosis of patients with heart failure: A large retrospective observational analysis from the Italian Network-Heart Failure (IN-HF) registryMatteo Bianco, Samuela Carigi, Renata De Maria, et al.Giornale Italiano Di Cardiologia (2006)|February 25, 2025
[Worsening heart failure: definition, management and treatment]Maria Vittoria Matassini, Paolo Manca, Raul Limonta, et al.Journal of Clinical Medicine|December 30, 2025
Risk Stratification Tools in Acute Heart Failure and Their Roles in Personalized Follow-UpVittoria Rizzello, Samuela Carigi, Renata De Maria, et al.Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Follow-up of patients with acute and chronic heart failure: risk stratification to diversify the pathway]Samuela Carigi, Vittoria Rizzello, Renata De Maria, et al.Giornale Italiano Di Cardiologia (2006)|December 12, 2022
[ANMCO Position paper: Evidence and practical indications for the use of low-dose rivaroxaban in stable coronary artery disease and peripheral artery disease]Stefania Angela Di Fusco, Vittoria Rizzello, Pietro Scicchitano, et al.The American Journal of Cardiology|November 26, 2009
Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemiaArend F L Schinkel, Abdou Elhendy, Ron T van Domburg, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 12, 2026
Hypokinetic nondilated cardiomyopathy: clinical characteristics, prognosis, and therapy response compared to dilated cardiomyopathyPaolo Manca, Samuela Carigi, Luca Fazzini, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|May 24, 2024
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular preventionLeonardo De Luca, Stefania Angela Di Fusco, Gianmarco Iannopollo, et al.Journal of Clinical Medicine|December 30, 2025
Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEFMaria Denitza Tinti, Luisa De Gennaro, Raul Limonta, et al.Pageof 8